NM_206933.4:c.14276G>A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS1
This summary comes from the ClinGen Evidence Repository: The c.14276G>A (p.Gly4759Glu) variant has been detected in at least 4 heterozygous individuals with clinical features of hearing loss or retinitis pigmentosa (PS4/PM3 not met; Partners LMM internal data, PMID 28041643). However, the filtering allele frequency (the lower threshold of the 95% CI of 102/24022) of the p.Gly4759Glu variant in the USH2A gene is 0.425% for African chromosomes by gnomAD, which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BS1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA180987/MONDO:0019501/005
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.14276G>A | p.Gly4759Glu | missense_variant | Exon 65 of 72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.14276G>A | p.Gly4759Glu | missense_variant | Exon 65 of 73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.00114 AC: 174AN: 152066Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000259 AC: 65AN: 251184Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135740
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461886Hom.: 0 Cov.: 33 AF XY: 0.0000756 AC XY: 55AN XY: 727244
GnomAD4 genome AF: 0.00115 AC: 175AN: 152184Hom.: 1 Cov.: 32 AF XY: 0.00102 AC XY: 76AN XY: 74390
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Observed in a patient with retinitis pigmentosa in published literature (Carss et al., 2017); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28041643) -
- -
not specified Benign:2
Variant summary: USH2A c.14276G>A (p.Gly4759Glu) results in a non-conservative amino acid change located in the Fibronectin type III domain (IPR003961) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00026 in 251184 control chromosomes, predominantly at a frequency of 0.0038 within the African or African-American subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in USH2A causing Usher Syndrome (0.00026 vs 0.011), allowing no conclusion about variant significance. c.14276G>A has been reported in the literature as a non-informative genotype with three other missense variants in the USH2A gene (phase not specified) in at-least one individual of African ethnicity reportedly affected with with Retinitis Pigmentosa (RP) analyzed by whole genome sequencing (WGS) and reported as "Partially Solved" (example, Carrs_2017). These report(s) do not provide unequivocal conclusions about association of the variant with Usher Syndrome.To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five clinical diagnostic laboratories and the ClinGen Hearing Loss Variant Curation Expert Panel have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple submitters reported the variant with conflicting assessments (VUS, n=4, likely benign, n=2 including the expert panel). Based on the evidence outlined above, the variant was classified as likely benign. -
The Gly4759Glu variant in USH2A: This variant is not expected to have clinical s ignificance because it has been identified in 0.34% (15/4406) of African America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs112459877). -
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
- -
Usher syndrome type 2A Uncertain:1
- -
Retinitis pigmentosa Uncertain:1
- -
Usher syndrome Benign:1
The c.14276G>A (p.Gly4759Glu) variant has been detected in at least 4 heterozygous individuals with clinical features of hearing loss or retinitis pigmentosa (PS4/PM3 not met; Partners LMM internal data, PMID 28041643). However, the filtering allele frequency (the lower threshold of the 95% CI of 102/24022) of the p.Gly4759Glu variant in the USH2A gene is 0.425% for African chromosomes by gnomAD, which is a high enough frequency to be classified as likely benign based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BS1). -
USH2A-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at